findmyKOL
Clinical trialNCT05839041Active, not recruitingPhase 2Interventional

A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

SponsorAviceda Therapeutics, Inc.Enrollment300Geographic Atrophy of the MaculaMacular Degeneration
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

56 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Associated Retina Consultants

    Gilbert, Arizona, United States

  • Arizona Retina and Vitreous Consultants

    Phoenix, Arizona, United States

  • Associated Retina Consultants

    Scottsdale, Arizona, United States

  • Retina Vitreous Associates Medical Group

    Beverly Hills, California, United States

  • Macula & Retina Institute

    Glendale, California, United States

  • Northern California Retina Vitreous Associates

    Mountain View, California, United States

  • Kaiser Permanente

    Riverside, California, United States

  • Retinal Consultants Medical Group

    Sacramento, California, United States

  • Retinal Consultants Medical Group, Inc.

    Sacramento, California, United States

  • West Coast Retina

    San Francisco, California, United States

  • Rca: California Retina Consultants

    Santa Barbara, California, United States

  • Retina Group of New England, Pc

    Waterford, Connecticut, United States

  • Rand Eye Institute

    Deerfield Beach, Florida, United States

  • Retina Group of Florida

    Fort Lauderdale, Florida, United States

  • Florida Retina Institute

    Orlando, Florida, United States

  • Retina Specialty Institute

    Pensacola, Florida, United States

  • Retina Vitreous Associates of Florida

    St. Petersburg, Florida, United States

  • Southern Vitreoretinal Associates

    Tallahassee, Florida, United States

  • Center for Retina & Macular Disease

    Winter Haven, Florida, United States

  • Southeast Retina Center

    Augusta, Georgia, United States

  • University Retina and Macula Associates

    Chicago, Illinois, United States

  • Illinois Retina Associates

    Oak Park, Illinois, United States

  • Midwest Eye Institute

    Indianapolis, Indiana, United States

  • Cumberland Valley Retina Consultants

    Hagerstown, Maryland, United States

  • Ophthalmic Consultants of Boston

    Boston, Massachusetts, United States

  • New England Retina Consultants

    Springfield, Massachusetts, United States

  • Retina Specialists of Michigan

    Grand Rapids, Michigan, United States

  • Associated Retinal Consultants

    Royal Oak, Michigan, United States

  • Retina Consultants of Minnesota

    Minneapolis, Minnesota, United States

  • Mississippi Retina Associates

    Jackson, Mississippi, United States

  • Sierra Eye Associates

    Reno, Nevada, United States

  • Retina Center of New Jersey

    Bloomfield, New Jersey, United States

  • Nj Retina

    Edison, New Jersey, United States

  • Retina-Vitreous Surgeons of Central Ny

    Syracuse, New York, United States

  • Long Island Vitreoretinal Consultants

    Westbury, New York, United States

  • North Carolina Retina Associates

    Wake Forest, North Carolina, United States

  • Retina Associates of Cleveland, Inc

    Beachwood, Ohio, United States

  • Retina Associates of Cleveland

    Cleveland, Ohio, United States

  • Retina Vitreous Center

    Edmond, Oklahoma, United States

  • Mid-Atlantic Retina

    Bethlehem, Pennsylvania, United States

16 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
2 May 2023
Primary completion
30 Apr 2026
Completion
31 Oct 2026
Last update posted
20 Nov 2025
Registered enrollment
300
Registry id
NCT05839041

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.